Vanguard Group Inc Adma Biologics, Inc. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 16,841,449 shares of ADMA stock, worth $319 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,841,449
Previous 18,198,796
7.46%
Holding current value
$319 Million
Previous $312 Million
7.06%
% of portfolio
0.01%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding ADMA
# of Institutions
390Shares Held
190MCall Options Held
2.53MPut Options Held
696K-
Black Rock Inc. New York, NY18.6MShares$354 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$244 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$217 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.67MShares$107 Million0.01% of portfolio
-
Morgan Stanley New York, NY4.91MShares$93.2 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.72B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...